M
Marta González-Vicent
Researcher at Boston Children's Hospital
Publications - 125
Citations - 2476
Marta González-Vicent is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 24, co-authored 109 publications receiving 1963 citations. Previous affiliations of Marta González-Vicent include Autonomous University of Madrid & Menéndez Pelayo International University.
Papers
More filters
Journal ArticleDOI
Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study
Federica Barzaghi,Laura C. Amaya Hernandez,Benedicte Neven,Silvia Ricci,Zeynep Yesim Kucuk,Jack J. Bleesing,Zohreh Nademi,Mary Slatter,Erlinda R. Ulloa,Anna Shcherbina,Anna Roppelt,Austen Worth,Juliana Silva,Alessandro Aiuti,Luis Murguia-Favela,Carsten Speckmann,Magda Carneiro-Sampaio,Juliana Folloni Fernandes,Safa Baris,Ahmet Ozen,Elif Karakoc-Aydiner,Ayca Kiykim,Ansgar Schulz,Sandra Steinmann,Lucia Dora Notarangelo,Eleonora Gambineri,Paolo Lionetti,William T. Shearer,Lisa R. Forbes,Caridad Martinez,Despina Moshous,Stéphane Blanche,Alain Fisher,Frank M. Ruemmele,Come Tissandier,Marie Ouachée-Chardin,Frédéric Rieux-Laucat,Marina Cavazzana,Waseem Qasim,Barbarella Lucarelli,Michael H. Albert,Ichiro Kobayashi,Laura C. Alonso,Cristina Díaz de Heredia,Hirokazu Kanegane,Anita Lawitschka,Jong Jin Seo,Marta González-Vicent,Miguel Angel Diaz,Rakesh K. Goyal,Martin Sauer,Akif Yesilipek,Minsoo Kim,Yesim Yilmaz-Demirdag,Monica Bhatia,Julie Khlevner,Erick J. Richmond Padilla,Silvana Martino,Davide Montin,Olaf Neth,Agueda Molinos-Quintana,Justo Valverde-Fernandez,Arnon Broides,Vered Pinsk,Antje Ballauf,Filomeen Haerynck,Victoria Bordon,Catharina Dhooge,Maria Laura Garcia-Lloret,Robbert G. M. Bredius,Krzysztof Kałwak,Elie Haddad,Markus G. Seidel,Gregor Dückers,Sung-Yun Pai,Sung-Yun Pai,Christopher C. Dvorak,Stephan Ehl,Franco Locatelli,Frederick D. Goldman,Andrew R. Gennery,M.J. Cowan,Maria Grazia Roncarolo,Rosa Bacchetta +83 more
TL;DR: Patients receiving chronic IS were hampered by disease recurrence or complications, impacting long‐term disease‐free survival, and when performed in patients with a low OI score, HSCT resulted in disease resolution with better quality of life, independent of age, donor source, or conditioning regimen.
Journal ArticleDOI
Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm.
Juliane Menezes,Francesco Acquadro,M Wiseman,Gonzalo Gómez-López,Rocio N. Salgado,J G Talavera-Casañas,Ismael Buño,José Cervera,Santiago Montes-Moreno,J.M. Hernández-Rivas,Rosa Ayala,Maria-Jose Calasanz,María José Larrayoz,L F Brichs,Marta González-Vicent,David G. Pisano,M A Piris,Sara Alvarez,J C Cigudosa +18 more
TL;DR: The first mutational profiling of BPDCN is provided and the data support the current WHO classification of the disease as a myeloid disorder and provide a biological rationale for the incorporation of epigenetic therapies for its treatment.
Journal ArticleDOI
Risk factors and outcome of COVID-19 in patients with hematological malignancies
José Luis Piñana,José Luis Piñana,Rodrigo Martino,Irene Garcia-Garcia,Rocío Parody,María Dolores Morales,Gonzalo Benzo,Irene Gómez-Catalan,Rosa Coll,Ignacio De La Fuente,Alejandro Luna,Beatriz Merchán,Anabelle Chinea,Dunia de Miguel,Ana Serrano,Carmen Eva Perez,Carola Diaz,Jose Lopez,Adolfo Saez,Rebeca Bailén,Teresa Zudaire,Diana Martínez,Manuel Jurado,María Calbacho,Lourdes Vázquez,Irene García-Cadenas,Laura Fox,Ana I. Pimentel,Guiomar Bautista,Agustin Nieto,Pascual Fernández,Juan Carlos Vallejo,Carlos Solano,Marta Valero,I Espigado,Raquel Saldaña,Luisa Sisinni,Josep-Maria Ribera,María-José Jiménez,Maria Trabazo,Marta González-Vicent,Noemí Fernández,Carme Talarn,Maria Carmen Montoya,Angel Cedillo,Anna Sureda +45 more
TL;DR: In most patients with hematological malignancies COVID-19 mortality was directly driven by older age, disease status, performance status, as well as by immune parameters and level of inflammation (high CRP), and use of azithromycin and low dose corticosteroids may be of value in very severe CO VID-19.
Journal ArticleDOI
Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients
Per Ljungman,Rafael de la Cámara,Lena Pérez-Bercoff,Manuel Abecasis,Jose Bartolo Nieto Campuzano,M. Jimena Cannata-Ortiz,Catherine Cordonnier,Hermann Einsele,Marta González-Vicent,Ildefonso Espigado,Jörg Halter,Rodrigo Martino,Bilal Mohty,Gülsan Türköz Sucak,Andrew J. Ullmann,Lourdes Vázquez,Katherine N. Ward,Dan Engelhard +17 more
TL;DR: A prospective study was performed to collect data regarding risk factors and outcome of A/H1N1 in hematopoietic stem cell transplant recipients and neutropenia and patient age were significant risk factors for death.
Journal ArticleDOI
Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results
TL;DR: Umbilical cord blood has been rapidly established as an alternative source of stem cells to bone marrow for allogeneic-related and unrelated hematopoietic transplantation and many aspects of CBT have been elucidated, while other questions remain unresolved.